Procalcitonin (PCT) Detection Reagent

Specialty coagulation reagent for measurement of protein C levels in patient samples. CE-marked for diagnostic coagulation testing.

A diagnostic reagent kit for detecting human procalcitonin using colloidal gold immunochromatography method. This test is used for detecting bacterial infections and sepsis.

Point-of-care testing reagent for in vitro diagnostic applications enabling rapid clinical assessment. Designed for distributed laboratory and bedside diagnostic implementation.

In vitro diagnostic product for identifying pathogenic bacteria in clinical samples. The reagent supports infectious disease diagnosis and infection control measures.

Biochemical reagent for measuring C-reactive protein levels in patient serum. Used as an inflammatory marker in clinical diagnostics for infection and inflammation assessment.

C-reactive protein test reagent for inflammation and infection detection in clinical and point-of-care applications.

Point-of-care testing reagent kit providing rapid diagnostic results outside traditional laboratory settings. Supports clinical decision-making in various healthcare environments.

A Particle-Enhanced Turbidimetric Immunoassay (PETIA) reagent kit for in vitro diagnostic testing of calprotectin in human plasma and serum samples. The assay is an open channel format that can be applied on a wide range of automated clinical chemistry analysers. Results are obtained in 10 minutes with a measuring range of 0.4-20 mg/L and total CV <4.0%. The kit contains R1 (54 mL) and R2 (9 mL) liquid reagents ready to use.

A smaller format Particle-Enhanced Turbidimetric Immunoassay (PETIA) reagent kit for in vitro diagnostic testing of calprotectin in human plasma and serum samples. The assay is an open channel format compatible with multiple clinical chemistry analysers. Results are obtained in 10 minutes with a measuring range of 0.4-20 mg/L. The kit contains R1 (30 mL) and R2 (5 mL) liquid reagents ready to use.

Immunoassay reagent for C-Reactive Protein measurement on chemistry analyzers. Used for monitoring important patient attributes in various clinical conditions including COVID-19 response protocols.

Reagent formulation for chemiluminescent immunoassay analyzers enabling sensitive detection of specific antigens and antibodies in clinical samples.

A diagnostic reagent for diagnosing heart diseases and evaluating the severity level of cardiac conditions. It measures N-terminal pro-B-type natriuretic peptide to assess cardiac dysfunction and heart failure.